68-4

110/136

430T, Isayama H, Okusaka T, Tsuyuguchi T, Hirooka Y, Furuse J, Maguchi H, Suzuki K, Yamazaki H, Kijima H, Yanagisawa A, Yoshida M, Yokoyama Y, Mizuno T, Endo I: Clinical practice guidelines for the manage-ment of biliary tract cancers 2019: The 3rd English edition. J Hepatobiliary Pancreat Sci, 2020, Online ahead of print. 32) Matsubara S, Nakagawa K, Suda K, Otsuka T, Isayama H, Nakai Y, Oka M, Nagoshi S: A Proposed Algorithm for Endoscopic Ultra-sound-Guided Rendezvous Technique in Failed Biliary Cannulation. J Clin Med, 2020; 9: E3879. 33) Takahashi R, Ijichi H, Sano M, Miyabayashi K, Mohri D, Kim J, Kimura G, Nakatsuka T, Fujiwara H, Yamamoto K, Kudo Y, Tanaka Y, Tateishi K, Nakai Y, Morishita Y, Soma K, Takeda N, Moses HL, Isayama H, Koike K: Soluble VCAM-1 promotes gemcitabine resis-tance via macrophage infiltration and predicts therapeutic response in pancreatic cancer. Sci Rep, 2020; 10: 21194. 34) Kanno A, Yasuda I, Irisawa A, Hara K, Ashida R, Iwashita T, Takenaka M, Katanuma A, Takikawa T, Kubota K, Kato H, Nakai Y, Ryozawa S, Kitano M, Isayama H, Kamada H, Okabe Y, Hanada K, Ohtsubo K, Doi S, Hisai H, Shibukawa G, Imazu H, Masamune A: Adverse events of Endoscopic Ultrasound- Guided Fine-Needle Aspiration for Histologic Diagnosis in Japanese Tertiary Centers: A Multicenter Retrospective Study. Dig Endosc, 2020, Online ahead of print. 35) Ishii S, Fujisawa T, Isayama H, Asahara S, Ogiwara S, Okubo H, Yamagata H, Ushio M, Takahashi S, Okawa H, Yamagata W, Okawa Y, Suzuki A, Takasaki Y, Ochiai K, Tomishima K, Saito H, Shiina S, Ikari T: Clinical Evalua-tion of a Newly Developed Guidewire for Pancreatobiliary Endoscopy. J Clin Med, 2020; 9: E4059. 36) Nakai Y, Isayama H, Wang HP, Rerknimitr R, Khor C, Yasuda I, Kogure H, Moon JH, Lau J, Lakhtakia S, Ratanachu-Ek T, Seo DW, Lee DK, Makmun D, Dy F, Liao WC, Draganov PV, Almadi M, Irisawa A, Katanuma A, Kitano M, Ryozawa S, Fujisawa T, Wallace MB, Itoi T, Devereaux B: International consensus statements for endoscopic manage-ment of distal biliary stricture. J Gastroen-terol Hepatol, 2020; 35: 967-979. 37) Ogiwara S, Furihata M, Inami Y, Okawa H, Nomoto Y, Kitamura T, Osada T,Nagahara A: Does Endoscopic Retrograde Cholangiopan-creatography Carry Higher Risk for Patients 90 Years and Older? A Single-Institution Retrospective Study. Med Sci Monit, 2020; 26: e928033. doi: 10.12659/MSM.928033. PMID: 33281183; 38) Heissig B, Salama Y, Takahashi S, Osada T, Hattori K: The multifaceted role of plasmin-ogen in inflammation: Cell Signal, 2020; 75: 109761. doi:10.1016/j.cellsig.2020.109761. Epub 2020 Aug 28. PMID: 32861744; PMCID: PMC7452830. 39) Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y: Outcome of patients with acute liver failure awaiting liver transplantation in Japan. Hepatol Res, 2020; 50: 1186-1195. 40) Amano N, Ikeda Y, Hayashida S, Takahashi S, Sato S, Murata A, Tsuzura H, Sato S, Shimada Y, Iijima K, Wada R, Nagahara A, Genda T: Prognostic significance of serum tyrosine concentration in patients with primary biliary cholangitis under ursodeoxycholic acid therapy. Hepatol Res, 2020; 50: 214-223. 41) Nozaki A, Atsukawa M, Kondo C, Toyoda H, Chuma M, Nakamuta M, Uojima H, Takaguchi K, Ikeda H, Watanabe T, Ogawa S, Itokawa N, Arai T, Hiraoka A, Asano T, Fujioka S, Ikegami T, Shima T, Ogawa C, Akahane T, Shimada N, Fukunishi S, Abe H, Tsubota A, Genda T, Okubo H, Mikami S, Morishita A, Moriya A, Tani J, Tachi Y, Hotta N, Ishikawa T, Okanoue T, Tanaka Y, Kumada T, Iwakiri K, Maeda S; KTK49 Liver Study Group: The effectiveness and safety of glecaprevir/pibren-tasvir in chronic hepatitis C patients with refractory factors in the real world: a compre-hensive analysis of a prospective multicenter study. Hepatol Int, 2020; 14: 225-238. 42) Toyoda H, Atsukawa M, Watanabe T, Nakamuta M, Uojima H, Nozaki A, Takaguchi K, Fujioka S, Iio E, Shima T, Akahane T, Fukunishi S, Asano T, Michitaka K, Tsuji K, Abe H, Mikami S, Okubo H, Okubo T, Shimada N,